Public-market screening, selected business fundamentals, valuation context, source-linked observations, risk factors, evidence gaps and questions for further review.
Altmani Investment Research
Restricted accessStructured investment research with business fundamentals in context.
Altmani Investment Research supports staged research on listed securities and their underlying issuers. It combines screening, selected financial and operating analysis, valuation context, risk factors and source review without presenting a personalized investment recommendation.
Access is limited to approved participants.
Eligible participants receive five introductory credits once after their first successful sign-in.
Defined scope
Research support—not a decision made for the user.
No buy, sell, hold, lend or invest instruction; no personalized suitability assessment, comprehensive company due diligence, credit rating, audit, assurance, fairness opinion or guarantee of value or performance.
Research journey
Five stages from selection to review.
Users control when research starts. Available results depend on the selected security, market coverage, source availability and data quality.
Choose the research scope
Select a market route, security type and ticker list. Changing sections does not start an analysis.
Run a rough screen
Compare up to 25 companies using a fast first-pass review. Rough screening is free.
Run a detailed screen
Narrow the list to up to 10 companies for a more selective comparison. Detailed screening is free.
Request a full analysis
Review one selected company through the deeper research workflow. A new full analysis uses one credit.
Review your research
Return to completed work, source dates, limitations and available research results in your account.
Current access model
The first successful sign-in grants five credits once. Rough and detailed screening are free. A new full company analysis uses one credit; credits are returned when a qualifying technical failure prevents completion.
Analysis coverage
What the research environment is designed to examine.
The framework applies only the analyses supported by the available information and relevant to the selected security. It does not claim that every measure is available for every company, market or security type.
Public-market screening
Structured comparison of listed securities using the information available for the selected market and security type.
Business fundamentals
Selected parts of the issuer’s operating performance, profitability, capital efficiency, liquidity, leverage and cash generation may be examined where suitable data is available.
Valuation context
Reference valuation measures, scenario assumptions and an indicative value estimate may be used to frame further research—not to predict an outcome.
Risk and evidence review
Supporting factors, adverse factors, blocking issues, source coverage, data dates and gaps are made visible for review.
Full company research
A deeper dossier may bring together analytical sections, source collection, primary-document checks and evidence controls for one selected issuer.
Research history
Signed-in users can return to their own screening and full-analysis results without presenting them as personalized advice.
Key outputs explained
Read the measure together with its evidence.
These labels describe how results may be presented inside the tool. A missing or unreliable input can limit or prevent a conclusion.
Composite measure
A structured comparison measure assembled from the available screening inputs. It helps organize candidates; it is not a credit score, rating or recommendation.
Value estimate
An indicative research estimate based on the data and assumptions available to the relevant analysis. It is not a guaranteed price or fairness opinion.
Margin of safety
The difference between the price used in the research and the indicative value estimate, shown as analytical context rather than a promise of return.
Data reliability
An assessment of whether the available evidence is sufficient for the particular calculation or conclusion. Insufficient evidence can block a conclusion.
Supporting factors
Facts or observations that support the research case, presented alongside their source context where available.
Risks and limitations
Adverse factors, missing information, methodological limits and uncertainties that may weaken or qualify the result.
Blocking factors
Conditions that prevent the framework from forming or advancing a research conclusion.
Thesis invalidation
Specific developments or evidence that would require the research view to be reconsidered.
Source coverage
The scope, period and number of materials reviewed, together with source dates and warnings where the record is incomplete.
Primary-document checks
A visible indication of whether a primary document was obtained, reviewed and used in the analysis.
Research conventions
Context remains as important as any calculation.
- Source and dateImportant observations should be read with the cited source, reporting period and data date.
- ComparabilityAccounting classifications, currencies, periods and issuer-specific definitions can limit comparisons.
- Missing evidenceWhere information is unavailable or insufficient, the tool may show an incomplete result or form no conclusion.
- ScenariosValuation and scenario outputs are conditional illustrations based on stated inputs—not predictions.
- User reviewUsers should verify material facts and consider qualified professional advice before acting.
Important limitations
Users remain responsible for their decisions.
Results depend on the accuracy, completeness, timing and classification of the underlying information. Market data, public filings and other sources may be incomplete, delayed, unaudited, revised or inconsistent. Coverage can differ by market, issuer and security type.
Altmani Investment Research and ALTA’s related analytical support provide general research information only. They are not presented as a registered securities dealer or adviser service and do not constitute investment, securities, legal, tax, accounting or credit advice. No advisory, fiduciary or agency relationship is created.
No outcome, value, return, solvency or future performance is promised. Before making a material decision, users should independently verify the source information and obtain advice from appropriately qualified and, where required, registered professionals.